Table 7.
The outcomes of using NIPPV compared to using NCPAP.
| Variables (Reference) | β | S.E. | p Value | Odds Ratio | 95% C.I. for Exp (β) | |
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Air leak | 1.253 | 1.039 | 0.228 | 3.500 | 0.456 | 26.841 |
| BPD | −0.526 | 0.797 | 0.509 | 0.591 | 0.124 | 2.818 |
| Moderate to severe BPD | −0.441 | 0.737 | 0.549 | 0.643 | 0.152 | 2.727 |
| Respiratory support at day 28 | −0.610 | 1.183 | 0.606 | 0.543 | 0.053 | 5.527 |
| O2 supplement at day 28 | −5.741 | 4.300 | 0.182 | 0.003 | 0.000 | 14.695 |
| Respiratory support at week 36 | −0.872 | 0.680 | 0.199 | 0.418 | 0.110 | 1.584 |
| O2 supplement at week 36 | −0.452 | 0.823 | 0.583 | 0.636 | 0.127 | 3.192 |
| Methylxanthines * | −5.096 | 7089 | 0.999 | 0.006 | 0.000 | - |
| IVH | 0.424 | 0.700 | 0.544 | 1.529 | 0.388 | 6.024 |
| IVH ≥ grade 3 | −4.273 | 4.326 | 0.323 | 0.014 | 0.000 | 67.054 |
| PVE | 1.101 | 0.717 | 0.125 | 3.008 | 0.738 | 12.263 |
| Cystic PVL | 1.292 | 0.980 | 0.187 | 3.640 | 0.534 | 24.831 |
| Posthemorrhagic hydrocephalus | 17.362 | 5340.852 | 0.997 | 34,747,980.8 | −0.982 | 1.006 |
| ROP | 1.102 | 0.886 | 0.213 | 3.010 | 0.531 | 17.082 |
| ROP ≥ stage 3 | 2.405 | 1.369 | 0.079 | 11.083 | 0.757 | 162.280 |
| NEC | 0.619 | 1.355 | 0.648 | 1.858 | 0.131 | 26.444 |
| NEC ≥ stage 2 | 18.139 | 5499.397 | 0.997 | 75,423,990.2 | 0.000 | - |
| PDA | −1.035 | 1.007 | 0.304 | 0.355 | 0.049 | 2.558 |
| Early-onset sepsis | 0.638 | 0.719 | 0.375 | 1.892 | 0.462 | 7.751 |
| Late-onset sepsis | −1.072 | 1.077 | 0.320 | 0.342 | 0.041 | 2.827 |
| PAH | 0.468 | 0.996 | 0.638 | 1.597 | 0.227 | 11.255 |
| Death | −3.897 | 2.087 | 0.062 | 0.020 | 0.000 | 1.214 |
| Higher respiratory support | −1.023 | 0.663 | 0.123 | 0.359 | 0.098 | 1.318 |
| More than 30 days of ventilator | 0.193 | 0.821 | 0.814 | 1.213 | 0.243 | 6.063 |
* Methylxanthines include caffeine and theophylline. S.E., Standard error of mean. C.I., Confidence Interval. p < 0.05. BPD: bronchopulmonary dysplasia; IVH: intraventricular hemorrhage; PVE: periventricular echogenicities; PVL: periventricular leukomalacia; ROP: retinopathy of prematurity; NEC: necrotizing enterocolitis; PDA: patent ductus arteriosus; PAH: pulmonary arterial hypertension.